| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ACR.21992 |
| P8608 | Fatcat ID | release_k5dp5x2t6vevncju5sg4udfpve |
| P932 | PMC publication ID | 3689861 |
| P698 | PubMed publication ID | 23436757 |
| P50 | author | Sonye K Danoff | Q60650324 |
| Lesly-Anne Samedy | Q63633686 | ||
| P2093 | author name string | John C Hall | |
| Lisa Christopher-Stine | |||
| Livia Casciola-Rosen | |||
| Kristie Owoyemi | |||
| Jessie Werner | |||
| P2860 | cites work | Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome | Q37983327 |
| Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response | Q41834681 | ||
| The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody | Q43638792 | ||
| Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. | Q44504653 | ||
| Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La. | Q47410756 | ||
| Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. | Q51040689 | ||
| The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. | Q54526303 | ||
| Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension. | Q54779169 | ||
| 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 | ||
| The association between Mi-2 antibodies and dermatomyositis | Q68936700 | ||
| The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen | Q73565827 | ||
| Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis | Q81726575 | ||
| ??? | Q28215495 | ||
| Autoantigen Ro52 is an E3 ubiquitin ligase | Q24296239 | ||
| Novel packages of viral and self-antigens are generated during apoptosis | Q27485110 | ||
| Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses | Q27860455 | ||
| TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity | Q28118562 | ||
| Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity | Q29615913 | ||
| RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease | Q33476226 | ||
| The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3 | Q33670447 | ||
| Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis | Q33704562 | ||
| Polymyositis and dermatomyositis (second of two parts) | Q33909233 | ||
| Polymyositis and dermatomyositis (first of two parts) | Q33911013 | ||
| Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system | Q34286612 | ||
| A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy | Q34520109 | ||
| Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects | Q34779213 | ||
| Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies | Q35036195 | ||
| The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study | Q35198594 | ||
| Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy | Q35909737 | ||
| Anti-Mi-2 antibodies | Q36167947 | ||
| A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature | Q37053219 | ||
| Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression | Q37480302 | ||
| Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis | Q37886653 | ||
| P433 | issue | 8 | |
| P921 | main subject | dermatomyositis | Q681160 |
| P304 | page(s) | 1307-1315 | |
| P577 | publication date | 2013-08-01 | |
| P1433 | published in | Arthritis Care and Research | Q15754720 |
| P1476 | title | Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum | |
| P478 | volume | 65 |
| Q38596370 | A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy. |
| Q41876423 | A case of sarcoidosis with interstitial lung disease mimicking clinically amyopathic dermatomyositis and rapidly progressive interstitial lung disease |
| Q64043005 | Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations |
| Q42147109 | An Atypical Clinical Course of Anti-MDA5 Antibody-positive Interstitial Lung Disease in a Patient with Three Deteriorations in 9 years |
| Q36150817 | An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-Nup syndrome |
| Q39080537 | Anti-MDA5 Antibody Dermatomyositis Overlap with Systemic Lupus Erythematosus: A Case Report and Review of the Literature |
| Q58087535 | Anti-MDA5 Antibody Spectrum in Western World |
| Q37704772 | Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis |
| Q34486301 | Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study |
| Q48330437 | Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report. |
| Q38879035 | Anti-MDA5-Positive Dermatomyositis Presenting as Fever of Unknown Origin |
| Q36893955 | Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis |
| Q48234140 | Associations between anti-melanoma differentiation-associated gene 5 antibody and demographics, clinical characteristics and laboratory results of patients with dermatomyositis: A systematic meta-analysis |
| Q51090216 | Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India. |
| Q88414351 | Autoantibodies in myositis |
| Q55425108 | Bench to bedside review of myositis autoantibodies. |
| Q61818182 | Biomarkers in Adult Dermatomyositis: Tools to Help the Diagnosis and Predict the Clinical Outcome |
| Q35999311 | Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies |
| Q58752627 | Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study |
| Q38851108 | Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease |
| Q92081179 | Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis/dermatomyositis |
| Q50187621 | Clinically amyopathic dermatomyositis associated with anti-MDA5 antibody |
| Q91869708 | Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies |
| Q36953554 | Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases |
| Q88324782 | Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies |
| Q41485219 | Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer |
| Q47235167 | Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review |
| Q64258228 | Disease Specific Autoantibodies in Idiopathic Inflammatory Myopathies |
| Q53375302 | Editorial: A New Classification of Adult Autoimmune Myositis. |
| Q55311957 | Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody. |
| Q36015534 | Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis |
| Q38763676 | Fibrosing myopathy in systemic sclerosis associates with higher mortality |
| Q64104368 | Hypomyopathic Dermatomyositis Presenting with Idiopathic CD4 T-lymphocytopenia and Delayed Anti-MDA5 Positivity |
| Q37706152 | IL-6, IL-8, and IL-10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis/dermatomyositis |
| Q38355216 | Idiopathic inflammatory myopathies-a review |
| Q33924451 | Idiopathic inflammatory myopathies. |
| Q92801301 | Increased Serum Matrix Metalloproteinase-9 Levels are Associated with Anti-Jo1 but not Anti-MDA5 in Myositis Patients |
| Q89497679 | Inflammatory Myopathy-Related Interstitial Lung Disease: From Pathophysiology to Treatment |
| Q93376373 | Interstitial Lung Disease and Pulmonary Fibrosis: A Practical Approach for General Medicine Physicians with Focus on the Medical History |
| Q90296527 | Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment |
| Q39335156 | Lung Manifestations in the Rheumatic Diseases |
| Q88324698 | Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies |
| Q26766526 | Management of interstitial lung disease associated with connective tissue disease |
| Q33814323 | Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ. |
| Q35281962 | Myositis autoantibodies and clinical phenotypes. |
| Q37368405 | Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research |
| Q38281749 | Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies |
| Q92955292 | Myositis-Related Interstitial Lung Diseases: Diagnostic Features, Treatment, and Complications |
| Q38646384 | Myositis-specific autoantibodies: an important tool to support diagnosis of myositis |
| Q36788809 | PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome |
| Q50206412 | Panniculitis as the initial manifestation of dermatomyositis with anti-MDA5 antibody |
| Q39425296 | Pharmacological management of dermatomyositis |
| Q30792028 | Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort |
| Q57753744 | Prevalence and reactivity of anti-melanoma differentiation-associated gene 5 (anti-MDA-5) autoantibody in Brazilian patients with dermatomyositis |
| Q26798023 | Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies |
| Q57753902 | Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report |
| Q36150826 | Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features |
| Q38664251 | Serological subsets of juvenile idiopathic inflammatory myopathies--an update |
| Q52958901 | Successful treatment with intravenous cyclophosphamide for anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis associated with myelodysplastic syndrome. |
| Q60949708 | Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools |
| Q38603422 | The Clinical Features of Myositis-Associated Autoantibodies: a Review |
| Q38139286 | The evolving spectrum of polymyositis and dermatomyositis--moving towards clinicoserological syndromes: a critical review |
| Q37022721 | The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes |
| Q38813275 | Update on the pharmacological treatment of adult myositis |
Search more.